Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > 63 Subjects as part of study

<< Previous

Bullboard Posts

Next >>

Comment by stockmonster6on Jun 21, 2021 10:01am

117 Views

Post# 33419615

RE:RE:RE:63 Subjects as part of study

Hello fellow investors,
Here's my take - and read the NR very closely.

They needed same # of positive as negative cases. I would suspect as Brazil is having issues with Covid infections, likely finding the negative cases was hard to do; not finding positive cases.

Next point to consider - it isn't about people taking the AcuVid. Read closer:

The RT-PCR results for the other 7 subjects will be received in the coming days.

THRM is waiting on the results of the RT-PCR tests - NOT results from AcuVid.

They already have the results from AcuVid, but need the last 7 PCRs to compare them for final numbers.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles